Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 2: | Line 2: | ||
==Diseases for which it was used== | ==Diseases for which it was used== | ||
*[[Colon cancer - historical|Colon cancer]] | *[[Colon cancer - historical|Colon cancer]] | ||
| − | *[[ | + | *[[Breast cancer - historical|Breast cancer]] |
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
*6/18/1990: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. | *6/18/1990: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. | ||
Revision as of 02:13, 28 April 2022
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 6/18/1990: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer.
Also known as
- Brand name: Ergamisol